rdf:type |
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0026336,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0041365,
umls-concept:C0229671,
umls-concept:C0278493,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1522484,
umls-concept:C1527148,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1711411,
umls-concept:C2911692
|
pubmed:issue |
11
|
pubmed:dateCreated |
2008-10-8
|
pubmed:abstractText |
The aim of this study was to develop a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1432-1335
|
pubmed:author |
pubmed-author:AndoMasashiM,
pubmed-author:FujiwaraYasuhiroY,
pubmed-author:KatsumataNoriyukiN,
pubmed-author:KounoTsutomuT,
pubmed-author:NakanoErikoE,
pubmed-author:NodaAyakoA,
pubmed-author:ShimizuChikakoC,
pubmed-author:TakeuchiMasahiroM,
pubmed-author:TamuraKenjiK,
pubmed-author:UnoHajimeH,
pubmed-author:YonemoriKanK,
pubmed-author:YunokawaMayuM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
134
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1199-206
|
pubmed:dateRevised |
2009-3-17
|
pubmed:meshHeading |
pubmed-meshheading:18528707-Adult,
pubmed-meshheading:18528707-Aged,
pubmed-meshheading:18528707-Antigens, Tumor-Associated, Carbohydrate,
pubmed-meshheading:18528707-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18528707-Area Under Curve,
pubmed-meshheading:18528707-Breast Neoplasms,
pubmed-meshheading:18528707-Carcinoembryonic Antigen,
pubmed-meshheading:18528707-Female,
pubmed-meshheading:18528707-Humans,
pubmed-meshheading:18528707-Menopause,
pubmed-meshheading:18528707-Middle Aged,
pubmed-meshheading:18528707-Mucin-1,
pubmed-meshheading:18528707-Neoplasm Metastasis,
pubmed-meshheading:18528707-Neoplasm Recurrence, Local,
pubmed-meshheading:18528707-Predictive Value of Tests,
pubmed-meshheading:18528707-Premenopause,
pubmed-meshheading:18528707-Tumor Markers, Biological
|
pubmed:year |
2008
|
pubmed:articleTitle |
Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.
|
pubmed:affiliation |
Breast and Medical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. kyonemor@ncc.go.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|